Bayer <10K >50K <10K to institution Blue Earth <10K <10K Clovis <10K <10K CTI Biopharma Spouse Dendreon <10K >50K <10K to institution Endocyte <10K <10K Ferring <10K <10K Genentech >50K to institution Hoffman/LaRoche >50K to institution Janssen <10K <10K Medivation >50K to institution <10K <10K Pfizer >50K to institution James Nicholas Merck <10K <10K trial – Support to my institution Sanofi <10K <10K See above Bayer <10K See above Oncogenex <10K See above Astellas <10K See above Janssen <10K <10K See above Kantoff Philip Astellas 0 0 Bellicum 0 0 BIND Biosciences <10K BN Immunotherapeutics <10K Cristal Therapeutics 0 Endocyte/TRM Oncology 0 Genentech/Roche <10K GTx 0 DRGT 10-50K 10-50K Ipsen Pharmaceuticals 0 Janssen <10K Metamark 10-50K 10-50K Medivation 0
Bayer Blue Earth Clovis CTI Biopharma Dendreon Endocyte Ferring Genentech Hoffman/LaRoche Janssen Medivation Pfizer <10K <10K <10K <10K <10K <10K <10K <10K >50K to institution >50K to institution >50K to institution >50K to institution >50K to institution >50K to institution <10K <10K <10K <10K <10K <10K <10K <10K Spouse James Nicholas Merck Sanofi Bayer Oncogenex Astellas Janssen <10K <10K <10K <10K <10K <10K <10K <10K <10K – trial Support to my institution See above See above See above See above See above Kantoff Philip Astellas Bellicum BIND Biosciences BN Immunotherapeutics Cristal Therapeutics Endocyte/TRM Oncology Genentech/Roche GTx DRGT Ipsen Pharmaceuticals Janssen Metamark Medivation 0 0 0 <10K <10K 0 0 <10K 0 10-50K 0 <10K 10-50K 0 0 10-50K 10-50K